SecBot SecBot
PRESS-RELEASE ·Filed Jun 8, 2026

VTAK

Catheter Precision, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed4mo ago WireGlobeNewswire
Press release · Announcement
Actionable Insight • Neutral

The deal lacks hard financial details and is unlikely to move VTAK's stock materially given its tiny market cap and non-core nature. Watch for the 8-K filing for deal terms and any cash impact.

DirectionNeutral
Confidencemedium
Horizonweeks
Latest settled — T+20d ⚠ clustered
VTAK ▼ -24.88% at T+20d
NEUTRAL call -24.88% · α vs SPY -26.51% · entry $1.02 → $0.7662
Next anchor: T+60d due 8w ago
Entry = T+0 close
Jun 8, 2026
via day close
T+1d
-2.25%
call -2.25% · α -1.95%
$0.9971
settled 5mo ago
T+5d
+2.94%
call +2.94% · α +0.83%
$1.05
settled 5mo ago
T+20d
-24.88%
call -24.88% · α -26.51%
$0.7662
settled 4mo ago
T+60d
Pending
due 8w ago

Price Chart

Loading chart...

Executive Summary

Catheter Precision (VTAK) subsidiary Flyte acquired ~2.9 million shares of Volato Group (SOAR), representing a ~7.5% stake. This is a small strategic investment in a different aviation-tech company, not a transformative event for VTAK given its ~$3M market cap.

Key Facts

  • Flyte (subsidiary of VTAK) acquired ~2.9M shares of SOAR for a ~7.5% ownership stake
  • Transaction supports Flyte's strategy to expand aviation ecosystem and seek partnerships
  • Investment provides growth capital and a strategic shareholder for SOAR
  • Deal size not disclosed; VTAK market cap is ~$3M, so any material cash outlay could be significant relative to its size

Financial Impact

Undisclosed amount. ~2.9M shares of SOAR acquired; VTAK market cap is ~$3M, so relative impact could be material if cash consideration was large, but no dollar amount provided.

cashinvestmentsstrategic positioning

Risk Factors

  • No financial terms disclosed, making it impossible to assess economic impact
  • VTAK is a medical device company investing in aviation — a significant strategic pivot that may dilute focus
  • Both companies have micro-cap profiles (~$3M and potentially similar), amplifying execution risk

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3308266
23 reports for VTAK
Performance horizon
67% Hit rate @ T+5 4 of 6 directional calls Went positive at some point 6 of 6 best @ T+60▲ +82.93%Jun 22, 2026
Filters
Rows
Reports for VTAK — sortable, filterable
TypeNow
Oct 9, 2026
18d ago
8-K
BEARISH ★ 7/10
$1.00 $0.8200▲ +18.00%▲ +16.51%$0.6500 (+35.00%)
Oct 5, 2026
22d ago
Press Release
NEUTRAL ★ 2/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Oct 2, 2026
25d ago
8-K
NEUTRAL ★ 5/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Oct 2, 2026
25d ago
Press Release
NEUTRAL ★ 4/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Sep 28, 2026
29d ago
Press Release
NEUTRAL ★ 2/10
$0.1467awaiting T+5—$0.6500 (+343.08%)
Sep 25, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$0.1467awaiting T+5—$0.6500 (+343.08%)
Aug 27, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$0.2027 $0.1966▼ −3.01%▼ −3.28%$0.6500 (+220.67%)
Aug 11, 2026
11w ago
Press Release
NEUTRAL ★ 2/10
$0.2900 $0.2229▼ −23.14%▼ −22.73%$0.6500 (+124.14%)
Aug 4, 2026
12w ago
Press Release
NEUTRAL ★ 3/10
$0.2760 $0.2930▲ +6.16%▲ +6.26%$0.6500 (+135.51%)
Jul 13, 2026
15w ago
EFFECT
BEARISH ★ 7/10
$0.6504 $0.5020▲ +22.82%▲ +21.87%$0.6500 (+0.06%)
Showing 10 of 23

US Market Status

Market Closed — Opens in 6h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 8, 2026